"U.S. Expert Panel Supports HIV-Prevention Pill for People at High Risk" - Dennis Thompson
A daily pill that can block transmission of HIV should be prescribed to people at high risk of infection with the AIDS-causing virus, according to a highly-influential panel of experts. The treatment -- called pre-exposure prophylaxis (PrEP) -- has proven highly effective at preventing HIV spread in clinical trials, an evidence review by the U.S. Preventive Services Task Force has concluded. "We have seen firsthand at our clinics how the scale up of PrEP can dramatically decrease the rates of new HIV infection, and improve the quality of life for those individuals who have access to this intervention," said Antonio Urbina, MD, associate professor of medicine and infectious diseases at the Icahn School of Medicine at Mount Sinai.
— Antonio Urbina, MD, Associate Professor, Medicine, Infectious Disease, Icahn School of Medicine at Mount Sinai
Additional coverage: WebMD; U.S. News & World Report